MenuMENU
Meetings & Events > Conferences & Courses > Annual Scientific Meeting > 2013 Annual Scientific Meeting > 2013 ASM Syllabus Home Page > Day 2 Agenda and Syllabus

RecycleACMT125wThe Changing Faces of Antidotes

Web-based Syllabus

Instructions:

Lecture slides are available as PDFs in color (1 slide per page) and black & white (3 slides per page). Only material submitted by the lecturer is available.The files contained on these pages are the intellectual property of the American College of Medical Toxicology and, the authors and speakers. No unauthorized download, copy or distribution of these files is permitted.

Click on Color or B&W for the lecture you would like, or right-click and select "Save As..."

Please note that the web-based syllabus will be updated as new or revised material is made available. When re-visiting the syllabus, please refresh your browser to ensure access to recent updates. Breakout sessions may feature handouts that will be made available during individual sessions.

A printed syllabus will not be available for attendees in San Juan. Please print material you require prior to arrival.

 

Day 2

Saturday, March 16, 2013

 

Syllabus

Content

7:00-8:00am
Committee Meetings

7:00-8:00am   Education Committee, Atlantic Room I & ll

7:00-8:00am   Research Committee, Miramar Room

 Committee & Section Meetings Complete Schedule
8:00am-5:00pm Poster Session Poster Display List - PDF
8:00-9:00am
Platform Session 2
Moderators: Eric Lavonas, MD, FACMT and Jeffrey Brent, MD, PhD, FACMT

Diethylene Glycol Metabolites are Associated with Diethylene Dlycol Poisoning in Humans
Joshua G Schier, MD, MPH, FACMT

Borderline and Long QT Interval with Medications Associated with QT Prolongation in Adolescent Athletes
Christopher Hoyte, MD

The Naloxone Trigger:  An Emergency Department Series
Kavita M. Babu, MD, FACMT        

A Missed Opportunity for Safe Opioid Use Using Electronic Pharmacopoeia 
Jeff Lapoint, DO

 
 
9:00-9:45am
Dextrose: The Forgotten Antidote
9:45-10:45am

Platform Session 3
Moderators:
Diane P. Calello, MD and Yaron Finkelstein, MD

Transaminase and Creatine Kinase Levels in Acetaminophen Overdose and Rhabdomyolysis
Joshua B. Radke, MD

A Prospective, Single Arm Trial of a 48 hour IV Acetylcysteine Protocol for Treatment of Acetaminophen Overdose
Kennon Heard, MD, FACMT

Billing and Reimbursement Records for a Bedside Toxicology Consult Service at a Tertiary Care Academic Center During Fiscal Year 2011-2012
Timothy J. Wiegand, MD, FACMT

Medical Toxicology Fellowship Program Trends: 2001-2012
Paul Wax, MD, FACMT

All Abstracts - JMT PDF
10:45-11:00am Break  
11:00am-12:30pm Breakout Workshops: Attend 2/3 sessions  
A. High Dose Insulin: Can There Be Too Much of a Good Thing?
Samuel J. Stellpflug, MD and Jon B. Cole, MD
 Handout Available at Session
B. Shaking Up the Coma Cocktail: Flumazenil Reconsidered
J. J. Rasimas, MD, PhD
C. Lipid Rescue: What We've Learned Thus Far - Timing, Dosing, and Safety Considerations
Theodore C. Bania, MD
Color
12:30-1:30pm Poster Session 1: Authors with Posters  
1:30-2:30pm
Fellows-in-Training LuncheonThe Challenges of Job Negotiations
Suzanne R. White, MD, MBA, FACMT
(Please RSVP to your invitation to reserve a lunch)
B&W 
2:00-4:30pm Afternoon Free and Committee Meetings  
 

2:00-3:00pm   ATSDR Network, Ocean Park Room

2:00-3:00pm   Recent Graduate Section, Grand Ballroom IV

2:30-3:30pm   MTFITA, Atlantic Room l

3:00-4:00pm   Telemedicine Sub-Committee, Atlantic Room ll

3:30-4:30pm   Enduring Education Committee, Miramar Room

 Committee & Section Meetings Complete Schedule
   
 
 

 Faculty

 
Babu125w  Dr. Kavita M. Babu is an attending physician in the Department of Emergency Medicine, Division of Medical Toxicology.  She is a graduate of Warren Alpert School of Medicine of Brown University where she also did her residency, followed by her Medical Toxicology Fellowship training at the University of Massachusetts Medical School.  She has served as a faculty member both at UMass Medical School and at the Warren Alpert School of Medicine of Brown University.  Dr. Babu recently rejoined the UMass faculty as our Medical Toxicology Fellowship Program Director.
Bania125w 
Dr. Theodore C. Bania is Director of Research and Toxicology at St. Luke’s-Roosevelt Hospital Center in NY and Assistant Professor of Medicine at Columbia University College of Physician and Surgeons.   A graduate of SUNY Downstate Medical College, he completed his Emergency Medicine Residency at New York Medical College-Metropolitan Hospital in 1991.  He then completed a fellowship in Medical Toxicology at the New York City Poison Control Center-NYU-Bellevue Hospital in 1993.  He completed a Master in Clinical Research at the Albert Einstein College of Medicine in 2001.  Dr. Bania has developed several basic science models evaluating a variety of toxins and therapies including intravenous fat emulsions.
 
Cole Dr. Jon Cole is board certified in both Medical Toxicology and Emergency Medicine. A graduate of the University of Colorado School of Medicine in 2006, he completed his residency in Emergency Medicine in 2009 at Hennepin County Medical Center, where he was Chief Resident. He then completed a fellowship in Medical Toxicology at Regions Hospital and the Hennepin Regional Poison Center in 2011. Upon graduation from fellowship he assumed the role of Medical Director of the Hennepin Regional Poison Center in Minneapolis, MN. Dr. Cole is an Assistant Professor of Emergency Medicine at the University of Minnesota Medical School. His research interests include poison-induced cardiogenic shock and acute agitation.
Heard Photo Dr. Kennon Heard is Medical Toxicology Fellowship Director at the Rocky Mountain Poison and Drug Center and Associate Professor of Emergency Medicine at the University Of Colorado School Of Medicine. He works and teaches at the University Of Colorado Hospital Emergency Department.  He has been teaching emergency medicine principle and toxicology on all levels since 1999. His research interests include antidotes, cocaine toxicity, misuse of over-the-counter analgesics, acetaminophen poisoning, geriatric pharmacology and research design.  He has participated in 12 clinical trials, and has been primary investigator for three.  He has authored over 100 papers and 20 book chapters in various areas of Emergency Medicine and Medical Toxicology.
Hoffman125w Dr. Robert S. Hoffman is Professor of Emergency Medicine and Medicine (Clinical Pharmacology) at New York University School of Medicine and Director, New York City Poison Control Center.  He is also Attending Physician, Department of Emergency Medicine at Bellevue Hospital Center. Dr. Hoffman received a BA in chemistry from Brandeis University in 1980 and immediately entered New York University School of Medicine where he received his medical degree. He completed a 3-year internship and residency in Internal Medicine also at the New York University School of Medicine, followed by a Fellowship in Medical Toxicology at the New York City Poison Center/Bellevue Hospital Center. He subsequently achieved Board Certification in Internal Medicine, Medical Toxicology, and Emergency Medicine. Dr. Hoffman has authored over 100 peer-reviewed publications in various aspects of toxicology that include basic science, animal and clinical investigations. He has also authored numerous textbook chapters for major references in Medicine and Emergency Medicine. He lectures around the world on various aspects of toxicology and has helped to establish poison control centers in both Europe and Asia. Dr. Hoffman has held offices in all 3 American Toxicology Societies, including being a member of the board of trustees of the American Academy of Clinical Toxicology; a member of the board of directors of the American Association of Poison Control Centers; and Secretary/Treasurer, Vice President, and President of the American College of Medical Toxicology.  In 2012, Dr. Hoffman received the ACMT Matthew J. Ellenhorn Award designed to honor medical toxicologists who have had a notable and illustrious career in the field and have promoted the advancement of the subspecialty. 
Hoyte125w

Dr. Christopher Hoyte is currently an Assistant Professor in the Department of Emergency Medicine and Medical Toxicology at the University of Colorado School of Medicine. He serves as an attending physician at the Rocky Mountain Poison and Drug Center in Denver, CO. Dr. Hoyte completed his residency training in emergency medicine at Cook County Hospital in Chicago, IL and then went on to complete a medical toxicology fellowship at the Rocky Mountain Poison and Drug Center.  Dr. Hoyte is also the medical director of the University of Colorado’s outpatient toxicology clinic. His research interests includes sports toxicology.

Lapoint125w

Dr. Jeff Lapoint completed his emergency medicine training at SUNY Upstate Medical University and his medical toxicology fellowship at the New York University/New York City Poison Control Center training program. He currently works as an attending physician in emergency medicine and medical toxicology for the Southern California Permanent Medical Group in San Diego, CA. His current activities center on longitudinal toxicology curriculum for the upcoming emergency medicine residency and inception of a toxicology consult service.  His main research focus is the utilization of game design principles in the creation of dynamic interactive toxicology simulations for use on mobile devices and the epidemiology of emerging drugs of abuse, specifically synthetic cannabinoids and novel amphetamines.

Radke125w

Dr. Joshua B. Radke is a first year toxicology fellow at the University of California, Davis Medical Center in Sacramento, California.  Dr. Radke received his undergraduate degree from the University of Iowa (Go Hawks!). After receiving his medical degree from the University of Iowa Carver College of Medicine in 2009, he finally escaped the cold winters of the Midwest and relocated to Northern California. Dr. Radke completed his residency in Emergency Medicine in 2012. 

Rasimas125w Dr. Joseph J. Rasimas attended the University of Scranton and graduated summa cum laude with degrees in biochemistry, mathematics, and philosophy. He completed the Medical Scientist Training Program at Penn State University, earning a Ph.D. in Chemical Biology (2002) and M.D. (2003). Upon graduation from the Penn State College of Medicine, Dr. Rasimas was honored for excellence in both psychiatry and medical toxicology. He matriculated to psychiatry residency training at the Mayo Clinic in Rochester, Minnesota. Dr. Rasimas received the National Institute of Mental Health (NIMH) Outstanding Resident Award in 2005 and was recognized by the American College of Psychiatrists with the Laughlin Fellowship in 2007. He is a member of a number of academic honor societies as well as the Association for the Advancement of Philosophy and Psychiatry. He has studied psychotherapy at the Minnesota Psychoanalytic Society and Institute and the Washington School of Psychiatry. Dr. Rasimas was a clinical fellow at the NIMH, training in consultation-liaison psychiatry, bioethics, and clinical research. He has served as a staff psychiatrist for Hershey Medical Center and remains an Associate Professor of Psychiatry and Emergency Medicine for the Penn State College of Medicine, there. He completed a medical toxicology fellowship, obtained board certification in Addiction Medicine, and then returned to NIMH to join the Intramural Research Program. Dr. Rasimas is pursuing an academic medical career at the interface of psychosomatic medicine, medical toxicology, and psychodynamic psychotherapy. His primary areas of clinical interest are pharmacotherapeutics, neuropsychiatric toxicity, psychoanalysis, and the phenomenology of suicide.
Schier 125w

Dr. Joshua G. Schier is board certified in Medical Toxicology and Emergency Medicine and received his MPH in Epidemiology from the Emory Rollins School of Public Health. He is currently the Lead of the Environmental Toxicology Team, in the National Center for Environmental Health at CDC in Atlanta, GA. He is also an Assistant Professor in Emergency Medicine (Medical Toxicology Section) in the Emory University School of Medicine, an Associate Director of the Emory/CDC Medical Toxicology Fellowship, and a Medical Toxicology Attending and Consultant for Grady Health Systems and the GA Poison Center.

Stellpflug185

Dr. Sam Stellpflug is the Twin Cities Medical Toxicology Fellowship Director, and primarily practices, teaches, and learns as a faculty physician in the Regions Hospital Department of Emergency Medicine and Clinical Toxicology Service in St. Paul.  He also functions as a consultant for the Hennepin Regional Poison Center, and his academic appointment is as an Assistant Professor of Emergency Medicine at the University of Minnesota Medical School. Following medical school at the University of Wisconsin he completed a residency in emergency medicine at Regions Hospital and then the medical toxicology fellowship in the Twin Cities, a joint effort between the Regions Hospital clinical service and the Hennepin Regional Poison Center. Sam's main research interest is in poison-induced cardiogenic shock, among other things.  

 

Wax125w

Dr. Paul M. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology. Currently, Dr. Wax is a Clinical Professor in Surgery (Emergency Medicine) at the University of Texas, Southwestern School of Medicine where he is a member of the Section of Medical Toxicology and Director of the Medical Toxicology Clinic. Before joining ACMT in 2008 as its Executive Director, and the University of Texas Southwestern in 2006 as a part-time faculty member, Dr. Wax had faculty appointments in the Departments of Emergency Medicine at the University of Rochester School of Medicine from 1991-2001 and the University of Arizona School of Medicine from 2001-2006. From 2002-2006 Dr. Wax served as the National Director of ACMT's Consultation Network to support the ATSDR Regional Offices and was co-founder of ACMT’s Chemical Agent of Opportunity course. From 1997-2006 Dr. Wax also served as one of the American Board of Emergency Medicine’s appointee’s on the Medical Toxicology Subboard. During this time Dr. Wax served as Editor of the Medical Toxicology Board Certification Examination as well as Chairman of the Subboard, and was also the primary author of the 2004 Core Content of Medical Toxicology. Dr. Wax has also served as a consultant to the Centers for Disease Control NCEH’s Division of Laboratory Sciences and was a member of NCEH/ATSDR Board of Scientific Counselors from 2006-2008.

WhiteS125w Dr. Suzanne R. White completed her undergraduate education at Adrian College. She received her medical degree and completed her residency in emergency medicine and medical toxicology at Wayne State University. In addition to receiving an MBA from the University of Tennessee, Dr. White also completed the Executive Leadership in Academic Medicine Fellowship at Drexel University. Dr. White is board certified in Emergency Medicine and Medical Toxicology, and is a practicing medical toxicologist and emergency physician. Dr. White is the past Medical Director for the Children’s Hospital of Michigan Regional Poison Control Center. She is the Emergency Physician-in-Chief for the Detroit Medical Center and the Dayandan Professor and Chair of Emergency Medicine at Wayne State University School of Medicine. In January 2011, Dr. White was named Executive Vice President and Chief Medical Officer of the Detroit Medical Center. Dr. White has chaired the Medical Toxicology Subboard of the American Board of Emergency Medicine. Dr. White has served as the Chair of the ACMT Awards Committee and Education Committee. She currently serves on the ACGME RRC for EM and the American Board of Pharmaceutical Specialties. Dr. White has interests in the areas of poison prevention, disaster, bioterrorism and weapons of mass destruction preparedness.
Wiegand125w

Dr. Timothy J. Wiegand is an Associate Clinical Professor in the Department of Emergency Medicine at the University of Rochester Medical Center and is Director of the bedside Toxicology Consult Service at Strong Memorial Hospital and Highland Hospital and of the outpatient Toxicology Consultation Clinic at Strong Memorial Hospital in Rochester, New York. Dr. Wiegand is Board Certified in both Internal Medicine as well as Medical Toxicology and completed additional fellowship training in Clinical Pharmacology at the University of California, San Francisco. Dr. Wiegand’s practice revolves mostly around the delivery of consultation toxicology, pharmacology and addiction services although has also been involved in poisoning prevention serving as either consultant or Assistant/Associate Medical Director Positions for several different Poison Control Centers including the San Francisco Division of the California Poison Control System and the Northern New England Poison and Drug Information Center before moving to Rochester and becoming the Director of the Ruth Lawrence Poison & Drug Information Center.  He is currently a consultant toxicologist for the SUNY Upstate Poison Center and active in their toxicology fellowship program. One of Dr. Wiegand’s particular interests is the intersection of addiction medicine and medical toxicology. He Chairs the Addiction Medicine Section for the American College of Medical Toxicology. Dr.Wiegand has an addiction medicine pharmacotherapy clinic at Huther-Doyle Chemical Dependency Treatment program, a 500-600 person capacity comprehensive drug and alcohol dependence treatment program in Rochester, New York and he became the Medical Director of Huther-Doyle in September, 2012.